• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail
-
-

2010 Warning Letters

Recently Posted | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996

Warning Letters issued in 2010

 

* Not issued: A close-out letter may issue when, based on FDA’s evaluation, the firm has taken corrective action to address the violations contained in the Warning Letter. This procedure applies to Warning Letters issued on or after September 1, 2009.

* N/A: Not applicable, the Warning Letter was issued prior to September 1, 2009.

Read more about warning and close-out letters

Posted on January 11, 2011

Letter Issue Date Company Name Issuing Office Subject Close Out Date
December 22, 2010 Access Bio, Inc. New Jersey District Office Lacks Premarket Approval/Adulterated Not Issued *
December 21, 2010 Klinge Chemicals Limited Center for Drug Evaluation and Research CGMP for Deviations/Adulterated Not Issued *
December 21, 2010 Tico's Mexican Foods, inc. Denver District Office Seafood HACCP/Insanitary Conditions/Adulterated Not Issued *
December 21, 2010 Natural Zing, LLC Baltimore District Office Unapproved New Drug Promotional Claims/Misbranded Not Issued *
December 21, 2010 CIBA Vision Puerto Rico, Inc. San Juan District Office CGMP/QSR/Medical Devices/Adulterated September 14, 2011
December 21, 2010 Natural Options Corp Florida District Office New Drug/Adulterated/Misbranded Not Issued *
December 21, 2010 Smith & Nephew Orthopaedics Gmbh Center for Devices and Radiological Health CGMP/QSR/Medical Devices/Adulterated Not Issued *
December 20, 2010 Peregrine Surgical Ltd Philadelphia District Office CGMP/QSR/Medical Devices/Adulterated Not Issued *
December 20, 2010 Wild Thymes Farm, Inc. New York District Office Acidified Foods/Adulterated Not Issued *
December 16, 2010 Verichem Laboratories, Inc. New England District Office CGMP/QSR/Medical Devices/Adulterated Not Issued *


 

Contact FDA

301-796-8490
FDA's Office of Critical Path Programs
-
-
-